With an extensive background as in-house counsel to several multibillion-dollar publicly traded life sciences companies, Greg Chopskie brings an insider’s knowledge to the development of effective legal strategies and tactics in both domestic and international IP disputes, with a unique capability in and familiarity with Hatch-Waxman litigation. His proficiency includes IP portfolio design, due diligence, international commercial transactions, and international competition matters. He is a strategic counselor in all phases of international disputes relating to complex IP portfolios, helping clients ensure company value is preserved and enhanced.
Before joining Morrison & Foerster, Mr. Chopskie was associate general counsel for intellectual property at Gilead Sciences, directing IP litigation in the U.S. and overseas. Prior to that he served in senior in-house counsel positions at Wyeth, Shionogi, and Pfizer.
During the course of his in-house career he led several ground-breaking initiatives to streamline legal services delivery, ameliorate complex global risks and seize commercial opportunity. Examples of this work include:
Mr. Chopskie began his legal career at an international intellectual property firm where he focused on life sciences litigation.
He is frequently acknowledged for his capabilities, including a recommendation from Legal 500 US in 2017 for Patent Litigation. He was also named a Corporate IP Star in 2016 by Managing Intellectual Property.
Mr. Chopskie holds a B.S. in biology, with a concentration in genetics from Georgetown University, and a J.D., cum laude, from George Mason University School of Law.
Mr. Chopskie is recommended by Managing Intellectual Property among its Corporate IP Stars (2016). He is also recommended by Legal 500 US 2017 in the practice area of Patent Litigation.
©1996-2018 Morrison & Foerster LLP. All rights reserved.